Research ArticleClinical Sciences
Radiopharmaceutical Treatment of Malignant Pheochromocytoma
James C. Sisson, Brahm Shapiro, William H. Beierwaltes, Jerry V. Glowniak, Masayuki Nakajo, Thomas J. Mangner, James E. Carey, Dennis P. Swanson, Jean E. Copp, Winston G. Satterlee and Donald M. Wieland
Journal of Nuclear Medicine February 1984, 25 (2) 197-206;
James C. Sisson
Brahm Shapiro
William H. Beierwaltes
Jerry V. Glowniak
Masayuki Nakajo
Thomas J. Mangner
James E. Carey
Dennis P. Swanson
Jean E. Copp
Winston G. Satterlee


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Radiopharmaceutical Treatment of Malignant Pheochromocytoma
James C. Sisson, Brahm Shapiro, William H. Beierwaltes, Jerry V. Glowniak, Masayuki Nakajo, Thomas J. Mangner, James E. Carey, Dennis P. Swanson, Jean E. Copp, Winston G. Satterlee, Donald M. Wieland
Journal of Nuclear Medicine Feb 1984, 25 (2) 197-206;
Radiopharmaceutical Treatment of Malignant Pheochromocytoma
James C. Sisson, Brahm Shapiro, William H. Beierwaltes, Jerry V. Glowniak, Masayuki Nakajo, Thomas J. Mangner, James E. Carey, Dennis P. Swanson, Jean E. Copp, Winston G. Satterlee, Donald M. Wieland
Journal of Nuclear Medicine Feb 1984, 25 (2) 197-206;
Jump to section
Related Articles
- No related articles found.
Cited By...
- ScRNA-seq of Diverse Pheochromocytoma Patients Reveals Distinct Microenvironment Characteristics and Supports an Informative Molecular Classification System
- Effects of Repeated 131I-Meta-Iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activity in Patients with Metastatic Neuroendocrine Tumors
- Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging
- Molecular and Therapeutic Advances in the Diagnosis and Management of Malignant Pheochromocytomas and Paragangliomas
- Extended stability of iobenguane under simulated clinical conditions